ended results issued Thank for our a reporting release morning, March everyone. This XXXX. joining we for you morning, XX, Good our first quarter press call.
free profitability on as closer to continued cash sustained pleased we basis. are and with our progress flow We a move generating
and from of sequential market financial growth in XX% we $X.X highlights $X cash increased flow maintained to our we of our revenue natural quarter the managing to we of position continue we of our increase consecutive a operations number which the end capital sequentially during and cash carefully receivables, gross and to products of increased QX all for share, through XXXX, also increase in are to when generated relationships, one margin Significant million, our achieved second channel to compared vendor included: inventory of working QX scrutiny million, retail and our the our sequential cash balance contributed all diligent collection conversion of QX. our at
And also efficiency a line gummies Daily Softgels including: Extra PlusCBD We efforts including numerous Balance, several PlusCBD and of our we Collection achieved SG&A. new softgels. cost new and QX, THC-free and Reserve continue to our gains a Collection our during structure, company overall Reserve in our operational several with areas, products, in including savings cost objectives cash efficiency launched lower Gummies, result
tax accrued areas Also, of QX, payroll is transaction statute we the on during our to an RSU significantly an these provide of details associated limitations This which Joerg our each his balance with issuance strengthens due will essentially during debt-free. now remarks. sheet, to reversed founder expiration.
our provide great XXXX, FDA us industry. saturation and brand that remain continuing environment including give in have spite we results by we in Congress Our early optimism our sensible the since will competitive challenges QX and inaction faced force for regulatory to industry a of a
an industry becoming and more is that model trustworthy. is to maturing, professional business take asset-light well Our positioned of advantage
including the properly our our and the in strength we impact of a brand how QX hard a of work good position company, several PlusCBD leverage realize in our starting are scaling of was years to distribution. us putting financial of the to example now positive assets,
site. This our to revenue higher. run revenue $X a in to per million-plus the side, revenue get rate goal near-term is back and the On quarter immediate goal company is
and great the in made working during remove BXB supply old we as retailers XXXX. brand inventory brands. overcoming more are to progress QX, through contraction we chain We During continue issues see experienced slow-moving in
retail As market I the selling of already top mentioned, to of share we continue the channel. product moving the with trust, channel, natural the or know brands list brand three that concentration range. be we see natural to to are we in and number the are the XX% one brands the and in in at sticking continue they top Customers and
channel Our BXC continues sales to improve.
activity. support nearly infrastructure BXC scale Our built for and unlimited is can and traffic
marketing basis return Our our on a targets. optimize refined daily to our on merchandising spend BXC ROI ad we ensure investment achieving and to are is that
results orders BXC seeing KPIs, increased are visitors, new and including AOV. critical in We subscription all revenue and
Brand prepared to education channel, evolves. are as take trust and consumer we will the and contraction, help grow BXC all category and share the increased channel market the grow
Our channels often and BXB the retailer work our customer. BXB customers our time, as even and about to transition or BXC BXC a synergistically from products learn try over then,
a area team. our focus also Company and is for brand awareness
social improvement our public we media saw QX, in efforts. During continued relations
rates engagements impressions, engagement Our are improving. all and
We by media to relevant to thought our as products the our high-quality position wellness feature are leader and outlets category. regularly a in covered national highlight CBD and
increasing. of is share Our voice
a During PlusCBD coverage. than we were total higher share Sciences in of featured and CV more media XX% Only one a CBD company do. of other QX, than has voice
continue strategy. will to for be growth development our important Product
XXXX May revenue mentioned since fiscal launched year of new was we XXXX. products from at As our year-end, XX%
course, ingredient our trusted. claim be Of for a are consumers function can they carry PlusCBD high-quality structure products, products increasingly that that multi-active looking want like but brands
trend and and plan new launch topical sleep, over-the-counter We to are addressing line. similar line, products to wellness this products our calm our our and relief including
line also and our reviews favorable customer extremely Reserve launched demand. innovative to We recently
and that innovate including customers product of need our for disorders. win products their customers. launch trust pain and to and We responsive loyalty and continue and new to our that specific claims states, sleep will strong new our are supports We and science anxiety, the existing will believe
frustrating, continue will and benefit to by we in state can optimistic but further remain industry On regulatory and category the make involved Inaction the grow our progress. at trusted level, progress. that consumers, is to required. environment a be will products matters, actively level to will Congress responsibly. and framework There patience at quality is sensible we all Congress be create the and will federal be regarding progress and significantly where pushing an companies know We FDA regulatory
Office development Canada, protection At European Australia with grant treatment application year-end, Union already of we countries. patents on use commented X its for corresponding our United development the of announced addiction, tobacco program formal filed CV also provide Japan received patent that we smokeless its in Sciences the drug the patent and key States, where in company certificate and commercial Patent for our from XXX-XXXX in patent markets, drug has similar asset. applications that granted
program this value has development and, We believe even program. partners of have program we internally, collaboration paused to drug we that though continue see development on continue this significant this to
industry The model with we well are efficient challenges positioned operating continue, our and structure. in an but business
We continue for increase and company growth operations, profitability. streamline to our realign and cost efficiency the
of in the made structuring now that strength which quality the a company's distribution. of have progress the repositioned strengths, our our organization cost-efficient to very in is lean, includes brands We products, employees, great our and trust assets our our leverage and
made revenue achieve years. of to lower able tough will the number competitors flow much than because at We over we our and the last profitability decisions positive many several a have be of cash that
I to and turn me pause over will now the Joerg. Let call
